<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:hpo ids='HP_0003745'>Sporadic</z:hpo> cases have reported the coexistence of <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> and <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the prevalence of the Brugada phenotype in <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> is unknown, particularly in non-Japanese populations </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we sought to examine the prevalence of the type 1 Brugada electrocardiogram (ECG) in a large European patient population undergoing intracoronary provocation testing for suspected <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: We retrospectively evaluated ECG data for the presence of type 1, 2, and 3 Brugada ECGs from 955 consecutive German patients without obstructive <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> undergoing intracoronary <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (ACH) provocation (ACH-test) </plain></SENT>
<SENT sid="4" pm="."><plain>Eight hundred and twenty-seven patients (age 63 Â± 12 years; 42% male) with complete ECG data were eligible for further analysis </plain></SENT>
<SENT sid="5" pm="."><plain>The ACH-test revealed <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> in 325 patients (39.3%) </plain></SENT>
<SENT sid="6" pm="."><plain>A Brugada ECG of any type was found in six patients (0.7%) at baseline and eight patients (0.9%) at any time </plain></SENT>
<SENT sid="7" pm="."><plain>There was no difference in the prevalence of <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> in patients with (37.5%) and without (39.3%) Brugada-type ECGs </plain></SENT>
<SENT sid="8" pm="."><plain>The type 1 Brugada ECG was not seen at baseline, but two type 1 Brugada ECGs were observed during ACH-administration into the right coronary artery (RCA; 0.2%), one with simultaneous RCA spasm and one without </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="28462">Ajmaline</z:chebi> provocation testing reproduced the type-1 Brugada ECG in the patient without <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> but she had no other features of the <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: This study reports a low prevalence of the type 1 Brugada ECG in the largest known European collection of intracoronary ACH provocation </plain></SENT>
<SENT sid="11" pm="."><plain>In these patients, we found no evidence for the coexistence of <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> and <z:e sem="disease" ids="C0010073" disease_type="Disease or Syndrome" abbrv="">coronary spasm</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>This is in contrast to available Japanese data </plain></SENT>
</text></document>